Method for isolating an intestinal cholesterol binding protein

Details for Australian Patent Application No. 2003253341 (hide)

International Classifications

Event Publications

30 October 2003 Complete Application Filed

Priority application(s): 02017504.8 06.08.02 EP

8 April 2004 Application Open to Public Inspection

Published as AU-B-2003253341

22 December 2005 Assignment before Grant

Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

23 April 2009 Application Accepted

Published as AU-B-2003253341

28 May 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 05 May 2009. Address for service in Australia - Watermark Patent & Trademark Attorneys 302 Burwood Road Hawthorn VIC 3122

24 September 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 05 May 2009

24 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.